Compounds > valproic acid

valproic acid and finasteride

valproic acid has been researched along with finasteride in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Reddy, DS; Rogawski, MA	1
Arimochi, H; Gotohda, T; Her, S; Lee, MS; Morita, K	1
Higashi, T; Nakashima, K; Nakatake, Y; Okumura, A; Tabuchi, M; Tsuneoka, Y; Yamada, M; Yoshizawa, K	1
Chen, G; Gu, Z; Yang, G	1

Reviews

2 review(s) available for valproic acid and finasteride

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Transdermal Drug Delivery for Hair Regrowth. Molecular pharmaceutics, 2021, 02-01, Volume: 18, Issue:2 Topics: Acrylates; Administration, Cutaneous; Alopecia; Drug Carriers; Finasteride; Hair Follicle; Humans; Janus Kinases; Minoxidil; Nanoparticles; Permeability; Signal Transduction; Skin; STAT Transcription Factors; Transdermal Patch; Valproic Acid	2021

Other Studies

8 other study(ies) available for valproic acid and finasteride

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:3 Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Enzyme Inhibitors; Epilepsy; Female; Finasteride; Menstruation; Oxidoreductases; Pentylenetetrazole; Pregnanolone; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Seizures; Steroids; Valproic Acid	2000
Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. Journal of neuroscience research, 2009, Aug-15, Volume: 87, Issue:11 Topics: Animals; Brain-Derived Neurotrophic Factor; Butyrates; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Finasteride; Gene Expression; Glial Fibrillary Acidic Protein; Histone Deacetylase Inhibitors; Hydroxamic Acids; Neuroglia; Rats; RNA, Messenger; Serotonin; Sodium Compounds; Steroids; Time Factors; Valproic Acid	2009
Benzothiazepines, diltiazem and JTV-519, exert an anxiolytic-like effect via neurosteroid biosynthesis in mice. Journal of pharmacological sciences, 2020, Volume: 143, Issue:3 Topics: 5-alpha Reductase Inhibitors; Animals; Anti-Anxiety Agents; Behavior, Animal; Carbamazepine; Diltiazem; Dose-Response Relationship, Drug; Finasteride; Male; Mice, Inbred C57BL; Neurosteroids; Pregnanolone; Thiazepines; Valproic Acid	2020